Advantix 250 mg + 1250 mg διάλυμα για επίχυση σε σημείο για σκύλους (> 10 kg ≤25 kg)
Advantix 250 mg + 1250 mg διάλυμα για επίχυση σε σημείο για σκύλους (> 10 kg ≤25 kg)
Authorised
- Imidacloprid
- Permethrin
Product identification
Medicine name:
Advantix 250 mg + 1250 mg διάλυμα για επίχυση σε σημείο για σκύλους (> 10 kg ≤25 kg)
Active substance:
- Imidacloprid
- Permethrin
Target species:
-
Dog
Route of administration:
-
Topical
-
External use
Product details
Active substance and strength:
-
Imidacloprid100.00/milligram(s)1.00millilitre(s)
-
Permethrin500.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma + Veterinaer Produkte GmbH
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- CY00001V-3
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 3/11/2025